Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Acute lymphoid leukemia is added, and the Genetic and Rare Diseases Information Center is listed under resources.
    Difference
    0.2%
    Check dated 2026-04-02T15:39:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' instead of 'No Results Posted', indicating that trial results have been submitted.
    Difference
    0.1%
    Check dated 2026-03-26T11:49:13.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated revision label to v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:33:53.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:09.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior notices about funding lapses and operating status (Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T14:20:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.